Mandate

Vinge advises Lantmännen in connection with formation of poultry group together with CapVest

April 05, 2013

Vinge has advised Lantmännen co-operative association in connection with the sale of Kronfågel to a newly-formed company which will become the Nordic region’s leading poultry producer and in which Lantmännen will remain a stakeholder with 48% of the voting capital.

The new group, which will be jointly owned together with the British private equity company, CapVest, will consist of Kronfågel, Swehatch and Skånefågel in Sweden, Danpo in Denmark and Cardinal Foods in Norway and will have an annual turnover of approximately SEK 5.4 billion. The transaction is subject to approval by the relevant competition authorities in Denmark, Norway and Sweden.

Vinge’s team consisted of responsible partner Christina Kokko together with associates Paul Dali, Johan Mattsson, Mia Örnfeldt, Gustav Jönsson and Filip Öhrner as well as Fredrik Gustafsson (employment and pensions), Karin Isacson (employment and pensions), Johan Cederblad (environmental and permit issues). Partner Mikael Ståhl and associates Louise Brorsson Salomon, Sofia Graflund and Albert Wållgren advised on external financing issues relating to the new group.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025